Home

manipulirati Ekstremno siromaštvo eksperimentalan embo molecular medicine Manija Prekoračiti natjecatelji

EMBO Molecular Medicine
EMBO Molecular Medicine

EMBO Molecular Medicine Impact Factor: scientometric... | Exaly
EMBO Molecular Medicine Impact Factor: scientometric... | Exaly

Mochly-Rosen Lab | Amit Joshi, Nay L Shaw, Hannes Vogel, Anna D Cunningham,  Mehrdad Shamloo, Daria Mochly-Rosen, and Carlos Gonzalez featured on the  cover of EMBO Molecular Medicine
Mochly-Rosen Lab | Amit Joshi, Nay L Shaw, Hannes Vogel, Anna D Cunningham, Mehrdad Shamloo, Daria Mochly-Rosen, and Carlos Gonzalez featured on the cover of EMBO Molecular Medicine

Ovid - EMBO Molecular Medicine | Wolters Kluwer
Ovid - EMBO Molecular Medicine | Wolters Kluwer

Wiley-VCH - EMBO Molecular Medicine
Wiley-VCH - EMBO Molecular Medicine

X \ EMBO Mol. Medicine على X: "Our June issue is online! Read our articles  on mitochondrial gene #HighThroughputScreening (our cover), #optogenetic,  #taupathology, #breastcancer, #mesothelioma, and more! -> Fully  #openaccess -> https://t.co ...
X \ EMBO Mol. Medicine على X: "Our June issue is online! Read our articles on mitochondrial gene #HighThroughputScreening (our cover), #optogenetic, #taupathology, #breastcancer, #mesothelioma, and more! -> Fully #openaccess -> https://t.co ...

High impact EMBO Molecular Medicine to Publish Under Open Access Model –  STM Publishing News
High impact EMBO Molecular Medicine to Publish Under Open Access Model – STM Publishing News

EMBO Mol. Medicine (@EmboMolMed) / X
EMBO Mol. Medicine (@EmboMolMed) / X

Our EMBO Molecular Medicine article most downloaded of 2021 for the journal  - The J. Tushir_Singh Lab
Our EMBO Molecular Medicine article most downloaded of 2021 for the journal - The J. Tushir_Singh Lab

Rui Carvalho on LinkedIn: Scientific Computing meets Data Analysis - MISCADA
Rui Carvalho on LinkedIn: Scientific Computing meets Data Analysis - MISCADA

TPC2 rescues lysosomal storage in mucolipidosis type IV, Niemann–Pick type  C1, and Batten disease — TIGEM
TPC2 rescues lysosomal storage in mucolipidosis type IV, Niemann–Pick type C1, and Batten disease — TIGEM

emm_oa_160-1497612432000.jpg
emm_oa_160-1497612432000.jpg

EMBO Molecular Medicine Template - EMBO Press
EMBO Molecular Medicine Template - EMBO Press

EMBO Molecular Medicine Impact Factor, Indexing, Ranking, Abbreviation 2023  - JournalsInsights
EMBO Molecular Medicine Impact Factor, Indexing, Ranking, Abbreviation 2023 - JournalsInsights

EMBO Mol. Medicine on X: "Happy New Year! Our first 2022 issue is online!  Read fully #openaccess: https://t.co/KyxkWdTowD Reviews on  #CaloricRestriction and biomarkers for #AlzheimersDisease, and articles on  #CancerImmunotherapy (cover ...
EMBO Mol. Medicine on X: "Happy New Year! Our first 2022 issue is online! Read fully #openaccess: https://t.co/KyxkWdTowD Reviews on #CaloricRestriction and biomarkers for #AlzheimersDisease, and articles on #CancerImmunotherapy (cover ...

EMBO Molecular Medicine Template - EMBO Press
EMBO Molecular Medicine Template - EMBO Press

Maternal Diet and Gut Bacteria Influence Offspring Immune Development »  Luxembourg Institute of Health
Maternal Diet and Gut Bacteria Influence Offspring Immune Development » Luxembourg Institute of Health

EMBO Molecular Medicine: Archive
EMBO Molecular Medicine: Archive

Stanford Chemical and Systems Biology | Stanford Medicine » Dr. Daria  Mochly-Rosen featured on the cover story in EMBO Molecular Medicine
Stanford Chemical and Systems Biology | Stanford Medicine » Dr. Daria Mochly-Rosen featured on the cover story in EMBO Molecular Medicine

Nanobodies dismantle post‐pyroptotic ASC specks and counteract inflammation  in vivo | EMBO Molecular Medicine
Nanobodies dismantle post‐pyroptotic ASC specks and counteract inflammation in vivo | EMBO Molecular Medicine

EMBO Molecular Medicine Distribution: scientometric... | Exaly
EMBO Molecular Medicine Distribution: scientometric... | Exaly

EMBO Molecular Medicine: Archive
EMBO Molecular Medicine: Archive

EMBO Molecular Medicine: CNIC scientists discover a new therapeutic target  for blocking early atherosclerosis in progeria - Biotech Spain
EMBO Molecular Medicine: CNIC scientists discover a new therapeutic target for blocking early atherosclerosis in progeria - Biotech Spain

EMBO Mol. Medicine (@EmboMolMed@sciencemastodon.com) - Science Mastodon
EMBO Mol. Medicine (@EmboMolMed@sciencemastodon.com) - Science Mastodon

Publications - ERA Lab
Publications - ERA Lab